ScholarIQanswers from OpenAlex
LivaNova
FunderResearch funding and supported work
LivaNova is a funder indexed in ScholarIQ from OpenAlex.
How many works does LivaNova have?
ScholarIQindexed works
LivaNova has 1,029 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for LivaNova?
ScholarIQopenalex
The OpenAlex for LivaNova is on the source record.
What are the most-cited papers on LivaNova?
ScholarIQmost cited works
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
Ewa A. Jankowska, Bridget‐Anne Kirwan, Mikhail Kosiborod, Javed Butler, Stefan D. Anker, Theresa A. McDonagh, Maria Dorobanţu, Jarosław Dróżdż, Gerasimos Filippatos, Andre Keren, Irakli Khintibidze, Hans Kragten, Felipe A. Martínez, Marco Metra, Davor Miličić, José Carlos Nicolau, Marcus Ohlsson, Alexander Parkhomenko, Domingo A. Pascual‐Figal, Frank Ruschitzka, David Sim, Hadi Skouri, Peter van der Meer, Basil S. Lewis, Josep Comín‐Colet, Stephan von Haehling, Alain Cohen‐Solal, Nicolas Danchin, Wolfram Doehner, Henry J. Dargie, Michael Motro, Tim Friede, Vincent Fabien, Fabio Dorigotti, Stuart Pocock, Piotr Ponikowski
Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction
Rahul Aggarwal, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones, Michaela Mattheus, Mark C. Petrie, Dominik Steubl, Mikhail Sumin, Vikram Thanam, Jacob A. Udell, Javed Butler
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair D Henderson, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Jean L. Rouleau, Karl Swedberg, Muthiah Vaduganathan, Dirk J van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Adel R. Rizkala, Eldrin F. Lewis, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray